150 related articles for article (PubMed ID: 27454841)
1. Impact of sex on the clinicopathological characteristics and prognosis of papillary thyroid cancer.
Yorke E; Melck A; Wiseman SM
Can J Surg; 2016 Aug; 59(4):287-8. PubMed ID: 27454841
[TBL] [Abstract][Full Text] [Related]
2. Predictors of incomplete response to therapy among Filipino patients with papillary thyroid cancer in a tertiary hospital.
Mendoza ES; Lopez AA; Valdez VA; Cunanan EC; Matawaran BJ; Kho SA; Sero-Gomez MH
J Endocrinol Invest; 2016 Jan; 39(1):55-62. PubMed ID: 26036600
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for persistent disease in papillary thyroid carcinoma with lymph node metastasis.
Oral A; Yazici B; Akgün A; Hassoy H; Özcan Z
Nucl Med Commun; 2016 Jul; 37(7):721-6. PubMed ID: 26967062
[TBL] [Abstract][Full Text] [Related]
4. Different Expression of Erythrocyte Sedimentation Rate and C-reactive Protein in Papillary Thyroid Carcinoma and Nodular Goiter.
Hou X; Jiang L; Chen C; Zhu X; Ge M
Clin Lab; 2015; 61(7):793-9. PubMed ID: 26299079
[TBL] [Abstract][Full Text] [Related]
5. Papillary thyroid carcinoma: prognostic significance of cancer presentation.
Choi H; Kasaian K; Melck A; Ong K; Jones SJ; White A; Wiseman SM
Am J Surg; 2015 Aug; 210(2):298-301. PubMed ID: 25997714
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological profile of papillary carcinoma of thyroid: A 10-year experience in a tertiary care institute in North Karnataka, India.
Rao R; Giriyan SS; Rangappa PK
Indian J Cancer; 2017; 54(3):514-518. PubMed ID: 29798949
[TBL] [Abstract][Full Text] [Related]
7. Diffuse sclerosing variant of papillary thyroid carcinoma--an update of its clinicopathological features and molecular biology.
Pillai S; Gopalan V; Smith RA; Lam AK
Crit Rev Oncol Hematol; 2015 Apr; 94(1):64-73. PubMed ID: 25577570
[TBL] [Abstract][Full Text] [Related]
8. Warthin-like variant of papillary thyroid carcinoma: single institution experience.
Jun HH; Kim SM; Hong SW; Lee YS; Chang HS; Park CS
ANZ J Surg; 2016 Jun; 86(6):492-4. PubMed ID: 24981584
[TBL] [Abstract][Full Text] [Related]
9. BRAF analysis before surgery for papillary thyroid carcinoma: correlation with clinicopathological features and prognosis in a single-institution prospective experience.
Galuppini F; Pennelli G; Vianello F; Censi S; Zambonin L; Watutantrige-Fernando S; Manso J; Nacamulli D; Lora O; Pelizzo MR; Rugge M; Barollo S; Mian C
Clin Chem Lab Med; 2016 Sep; 54(9):1531-9. PubMed ID: 26863344
[TBL] [Abstract][Full Text] [Related]
10. BRAF analysis by fine needle aspiration biopsy of thyroid nodules improves preoperative identification of papillary thyroid carcinoma and represents a prognostic factor. A mono-institutional experience.
Pelizzo MR; Boschin IM; Barollo S; Pennelli G; Toniato A; Zambonin L; Vianello F; Piotto A; Ide EC; Pagetta C; Sorgato N; Torresan F; Girelli ME; Nacamulli D; Mantero F; Mian C
Clin Chem Lab Med; 2011 Feb; 49(2):325-9. PubMed ID: 21175381
[TBL] [Abstract][Full Text] [Related]
11. The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study.
Elisei R; Viola D; Torregrossa L; Giannini R; Romei C; Ugolini C; Molinaro E; Agate L; Biagini A; Lupi C; Valerio L; Materazzi G; Miccoli P; Piaggi P; Pinchera A; Vitti P; Basolo F
J Clin Endocrinol Metab; 2012 Dec; 97(12):4390-8. PubMed ID: 23066120
[TBL] [Abstract][Full Text] [Related]
12. [Follicular cell (papillary and follicular) thyroid carcinoma, genetic inheritance, and molecular diagnostic markers].
Kazubskaia TP; Kozlova VM; Kondrat'eva TT; Pavlovskaia AI; Marakhonov AV; Baranova AV; Ivanova NI; Stepanova AA; Poliakov AV; Belev NF; Brzhezovskiĭ VZh
Arkh Patol; 2014; 76(5):3-12. PubMed ID: 25543402
[TBL] [Abstract][Full Text] [Related]
13. Lymphocytic thyroiditis on histology correlates with serum thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: impact on detection of serum thyroglobulin.
Latrofa F; Ricci D; Montanelli L; Rocchi R; Piaggi P; Sisti E; Grasso L; Basolo F; Ugolini C; Pinchera A; Vitti P
J Clin Endocrinol Metab; 2012 Jul; 97(7):2380-7. PubMed ID: 22539585
[TBL] [Abstract][Full Text] [Related]
14. Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine-needle aspiration specimens of papillary thyroid carcinoma.
Zhao H; Zhang ZH; Zhou B; Xiao T; Pan QJ; Guo HQ
Diagn Cytopathol; 2015 Oct; 43(10):786-90. PubMed ID: 26152656
[TBL] [Abstract][Full Text] [Related]
15. The role of BRAF V600E mutation as a potential marker for prognostic stratification of papillary thyroid carcinoma: a long-term follow-up study.
Daliri M; Abbaszadegan MR; Bahar MM; Arabi A; Yadollahi M; Ghafari A; Taghehchian N; Zakavi SR
Endocr Res; 2014; 39(4):189-93. PubMed ID: 24679337
[TBL] [Abstract][Full Text] [Related]
16. Age- and Gender-Specific Risk of Thyroid Cancer in Patients With Familial Adenomatous Polyposis.
Uchino S; Ishikawa H; Miyauchi A; Hirokawa M; Noguchi S; Ushiama M; Yoshida T; Michikura M; Sugano K; Sakai T
J Clin Endocrinol Metab; 2016 Dec; 101(12):4611-4617. PubMed ID: 27623068
[TBL] [Abstract][Full Text] [Related]
17. Synchronous and antecedent nonthyroidal malignancies in patients with papillary thyroid carcinoma.
Murray SE; Schneider DF; Bauer PS; Sippel RS; Chen H
J Am Coll Surg; 2013 Jun; 216(6):1174-80. PubMed ID: 23522438
[TBL] [Abstract][Full Text] [Related]
18. BRAF mutation analysis of fine-needle aspiration biopsies of papillary thyroid carcinoma: impact on diagnosis and prognosis.
Colanta A; Lin O; Tafe L; Ghossein R; Nafa K; Mitchell T; Ladanyi M; Arcila M
Acta Cytol; 2011; 55(6):563-9. PubMed ID: 22156467
[TBL] [Abstract][Full Text] [Related]
19. Pediatric patients with multifocal papillary thyroid cancer have higher recurrence rates than adult patients: a retrospective analysis of a large pediatric thyroid cancer cohort over 33 years.
Lee YA; Jung HW; Kim HY; Choi H; Kim HY; Hah JH; Park DJ; Chung JK; Yang SW; Shin CH; Park YJ
J Clin Endocrinol Metab; 2015 Apr; 100(4):1619-29. PubMed ID: 25632969
[TBL] [Abstract][Full Text] [Related]
20. Hashimoto's thyroiditis and papillary thyroid carcinoma. Are cytokeratin 19 and P63 proteins of any diagnostic value?
Divani SN; Kalodimos GP; Lioupis MA; Syrmos NC
Hell J Nucl Med; 2016; 19(3):250-253. PubMed ID: 27824965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]